Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sequence-based drug design as a concept in computational drug design
Lifan Chen, Zisheng Fan, Jie Chang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Mingyang Zhang, Ting Chen, Xun Lu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 104
Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis
Zhenhui Wu, Shupeng Chen, Yihao Wang, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 22
Artificial intelligence in drug development
Kang Zhang, Xin Yang, Yifei Wang, et al.
Nature Medicine (2025) Vol. 31, Iss. 1, pp. 45-59
Closed Access | Times Cited: 12
Agents for the Treatment of Gout: Current Advances and Future Perspectives
Xiaoyi Zeng, Yajing Liu, Yuxin Fan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14474-14493
Closed Access | Times Cited: 24
Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery
Xiaochu Tong, Ning Qu, Xiangtai Kong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
DrugReAlign: a multisource prompt framework for drug repurposing based on large language models
Jinhang Wei, Linlin Zhuo, Xiangzheng Fu, et al.
BMC Biology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Mitochondrial Sirtuins in Cancer: A Revisited Review from Molecular Mechanisms to Therapeutic Strategies
Hui Shen, Wei Ma, Yue Hu, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2993-3013
Open Access | Times Cited: 9
From scientific theory to duality of predictive artificial intelligence models
Jürgen Bajorath
Cell Reports Physical Science (2025), pp. 102516-102516
Open Access | Times Cited: 1
TEFDTA: a transformer encoder and fingerprint representation combined prediction method for bonded and non-bonded drug–target affinities
Zongquan Li, Pengxuan Ren, Hao Yang, et al.
Bioinformatics (2023) Vol. 40, Iss. 1
Open Access | Times Cited: 19
Drug discovery and development in the era of artificial intelligence: From machine learning to large language models
Shenghui Guan, Guanyu Wang
Artificial Intelligence Chemistry (2024) Vol. 2, Iss. 1, pp. 100070-100070
Open Access | Times Cited: 8
In silico off-target profiling for enhanced drug safety assessment
Jin Liu, Yike Gui, Jingxin Rao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2927-2941
Open Access | Times Cited: 7
Ginkgetin Alleviates Inflammation and Senescence by Targeting STING
Yadan Liu, Jialin Ye, Zisheng Fan, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 7
Hydrophobic tagging of small molecules: an overview of the literature and future outlook
Yang Zhou, Fan Zhou, Shujing Xu, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 7, pp. 799-813
Closed Access | Times Cited: 6
A review of transformers in drug discovery and beyond
Jian Jiang, Long Chen, Ke Lü, et al.
Journal of Pharmaceutical Analysis (2024), pp. 101081-101081
Open Access | Times Cited: 6
Structural Relationships to Efficacy for Prazole‐Derived Antivirals
David A. Nyenhuis, Susan M. Watanabe, Rebecca Bernstein, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 4
Development of small molecule drugs targeting immune checkpoints
Luoyi Chen, Xinchen Zhao, Xiaowei Liu, et al.
Cancer Biology and Medicine (2024), pp. 1-18
Open Access | Times Cited: 4
Generative design of compounds with desired potency from target protein sequences using a multimodal biochemical language model
Hengwei Chen, Jürgen Bajorath
Journal of Cheminformatics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Age-related decline in CD8+ tissue resident memory T cells compromises antitumor immunity
Siyu Pei, Xiuyu Deng, Ruirui Yang, et al.
Nature Aging (2024)
Closed Access | Times Cited: 4
Bridging Traditions and Technology: The Role of Ethnopharmacology in Shaping Next‐Generation Multidisciplinary Researchers
Ee Wern Tan, Lori Low, Atanas G. Atanasov, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access
Undeveloped Region in Target-Strategies and Potential in Antiviral Drug Discovery
Shaoqing Du, Xinyong Liu, Xueping Hu, et al.
Pharmaceutical Fronts (2025)
Open Access
Folding-Based End-To-End Chemical Drug Design with Uncertainty Estimation: Tackling Hallucination in the Post-GPT Era
Feisheng Zhong, Rongcai Yue, Jin-xing Chen, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
druglikeFilter 1.0: An AI powered filter for collectively measuring the drug-likeness of compounds
Minjie Mou, Yintao Zhang, Yuntao Qian, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101298-101298
Open Access
Chemical language models for molecular design
Jürgen Bajorath
Molecular Informatics (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 10
Conformational Space Profiling Enhances Generic Molecular Representation for AI‐Powered Ligand‐Based Drug Discovery
Lin Wang, Shihang Wang, Hao Yang, et al.
Advanced Science (2024) Vol. 11, Iss. 40
Open Access | Times Cited: 3
Identifying compound-protein interactions with knowledge graph embedding of perturbation transcriptomics
Shengkun Ni, Xiangtai Kong, Yingying Zhang, et al.
Cell Genomics (2024), pp. 100655-100655
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top